Welcome to our dedicated page for Tilt Hldgs news (Ticker: TLLTF), a resource for investors and traders seeking the latest updates and insights on Tilt Hldgs stock.
TILT Holdings Inc. (TLLTF) generates a wide range of company news tied to its role as a global provider of cannabis business solutions. Its disclosures describe a portfolio that includes inhalation technologies, cultivation, manufacturing, processing, brand development and retail, with a core focus on Jupiter Research LLC, a wholly owned subsidiary active in vaporization hardware design, research, development, manufacturing and distribution. News about TILT often highlights how these activities support cannabis brands and retailers across North America, South America, Israel and the European Union.
Recent announcements show that TILT’s news flow covers both operational performance and strategic restructuring. Earnings releases discuss quarterly financial and operating results, including revenue trends, gross margin dynamics and the impact of strategic shifts such as divesting plant-touching assets in Massachusetts and Ohio or transitioning parts of Jupiter’s business to a commission-based model. Operational updates also describe regulatory approvals, such as European Union medical device certification for a handheld liquid inhalation device developed by Jupiter, and agreements with partners like Curaleaf International for commercialization in medical markets.
Another important stream of news relates to capital structure and creditor arrangements. TILT has reported entering into secured note purchase agreements for bridge financing, receiving default notices from landlords on certain cultivation properties, and negotiating forbearance arrangements. The company has also issued multiple releases about its CCAA restructuring process in the Supreme Court of British Columbia, including the initial order granting creditor protection, the proposed plan of arrangement to take the company private, and notices of meetings for noteholders.
For users following TLLTF on this news page, the coverage provides a consolidated view of TILT’s financial results, restructuring milestones, asset sales, regulatory certifications and governance events such as shareholder meeting outcomes. Investors and observers can use this archive to trace how TILT’s strategy has evolved toward Jupiter-centered, asset-light operations and to understand the context behind its delisting and restructuring decisions.
TILT Holdings (OTC:TLLTF) announced that on Nov 17, 2025 the Supreme Court of British Columbia granted a Meeting Order under the Companies' Creditors Arrangement Act to hold a noteholder meeting on Dec 1, 2025.
The Meeting will ask noteholders to vote to approve a CCAA Plan. If approved by the required majority, the company intends to seek a court sanction order at a hearing scheduled for Dec 5, 2025 at 2:00 PM PT. Court filings and meeting materials are available on the court-appointed monitor's website.
TILT Holdings (OTCID: TLLTF) announced that trading in its securities was suspended on November 7, 2025 after the Supreme Court of British Columbia issued an initial order granting the company protection under the Companies’ Creditors Arrangement Act (CCAA). Cboe Canada notified TILT that trading of its common shares was suspended under Section 11.03 of the Cboe listing manual, and Cboe issued a bulletin to that effect. The company’s securities were also halted from quotation on the OTCID marketplace on November 7, 2025. Cboe’s Notice Letter states the common shares will be officially delisted on November 18, 2025, and there is no assurance the suspension will be lifted before delisting.
TILT Holdings (OTCID: TLLTF) announced it has entered a restructuring support agreement with holders of its senior secured notes and obtained an initial order under the CCAA from the Supreme Court of British Columbia. The Court appointed PricewaterhouseCoopers as Monitor, granted a stay of proceedings and allowed the company to raise up to US$2.0 million of bridge notes from existing noteholders to fund operations during the process. The proposed Plan would take the company private by cancelling existing equity and issuing equity to noteholders, and a Noteholders meeting is anticipated on Nov 17, 2025. Trading of common shares is halted and delisting is anticipated.
The Board remains in place; subsidiaries will continue regular operations.
TILT Holdings (OTCID: TLLTF), a global cannabis business solutions provider, has completed the sale of two Massachusetts dispensaries to In Good Health for $1.75 million. This transaction, initially announced on February 3, 2025, is part of TILT's strategic alternatives review.
Under the agreement, In Good Health will operate the Taunton location, while the Brockton dispensary has been closed. Highgate Capital Partners served as the broker for this transaction, which represents a significant step in TILT's strategic review process.
TILT Holdings (OTCID: TLLTF) reported Q2 2025 results, highlighting its strategic transformation into an asset-light business focused on its Jupiter vaporization hardware segment. Revenue from continuing operations was $10.5 million, down from $19.0 million year-over-year, with a net loss of $9.2 million.
Key developments include receiving regulatory approval for Massachusetts dispensary sale, establishing a management agreement with MariMed for Standard Farms Pennsylvania, and achieving EU MDR certification for their QMID™ handheld vaporizer. The company maintains $2.0 million in cash and equivalents, received a $3.5 million IRS refund for Employee Retention Credit, and reported an Adjusted EBITDA of $(2.0) million.
Curaleaf International and Jupiter Research (TLLTF) have secured EU medical device certification for Europe's first handheld liquid inhalation device designed for medical cannabis administration. The device, certified as a Class IIa medical device under EU Regulation 2017/745, features a magnetic snap-in cartridge and rechargeable power supply for consistent cannabinoid delivery.
The certification enables commercialization across multiple global markets, including European countries, the UK, Canada, and Australasia. The device's technical file and EU Declaration of Conformity were approved by an EU Notified Body, validating its quality, safety, and clinical effectiveness.
TILT Holdings (OTCPK: TLLTF) has scheduled its first quarter 2025 earnings conference call for May 15, 2025, at 5:00 p.m. ET. The company, a global provider of cannabis business solutions specializing in inhalation technologies, cultivation, manufacturing, processing, brand development and retail, will release its financial results for the quarter ended March 31, 2025, prior to the call.
The conference call will feature TILT management presenting the company's business strategy and financial results, followed by a Q&A session. Participants can join using the toll-free number (877) 423-9813 or international number (201) 689-8573. A webcast replay will be available in the investor relations section of TILT's website.
TILT Holdings (OTCQB: TLLTF) has received default notices from Innovative Industrial Properties (IIP) subsidiaries for two properties due to outstanding rental payments. The defaults concern properties in White Haven, PA and Taunton, MA.
The White Haven property default amounts to $1,130,592.57 in unpaid base rent, additional rent, and security deposit. The Taunton property default totals $2,996,786.42, including base rent, additional rent, late charges, interest, and security deposit.
Following the notices, TILT has initiated negotiations with IIP and has made payments for April rent obligations. IIP accepted these payments in exchange for forbearance from pursuing termination and eviction. TILT states it is committed to negotiating to resolve the outstanding amounts.